Our take
ExcelsiusGPS is the spine specialist. Its rigid arm holds the planned trajectory, force sensing flags skiving, and the system can run as a robot or as navigation only.1
It accepts any preoperative CT, intraoperative CT, or fluoroscopy, but it is built around Globus instruments and implants, and Globus publishes no price.1
Scores by criterion
Pricing transparency, 3.0: Globus publishes no price; buyers request a spec sheet or demo.1
Product maturity, 8.0: the platform covers TLIF, LLIF, sacroiliac fixation, and cranial procedures, with exchangeable end effectors, force deflection sensing, and an expandable interbody module.1
Deployment evidence, 7.0: Globus does not publish an installed base. Its enabling technology sales were 141.0 million dollars in 2025, down from 154.0 million in 2024, though the fourth quarter grew 19%.2
Company durability, 9.0: Globus Medical reported 2025 net sales of 2.94 billion dollars, up 16.7%.2
Ease of integration, 7.0: ExcelsiusGPS works with any preoperative CT, intraoperative CT, or fluoroscopy imaging system, and its floor-mounted stabilizers do not attach to the bed or patient.1
Each criterion is defined on our methodology page.
Who uses ExcelsiusGPS and what it's for
The buyer is a spine or neurosurgery program that wants robotic trajectory guidance with flexible imaging.1
Robotic arm and navigation
The rigid arm aligns to the planned trajectory, integrated instruments remove the need for K-wires in less invasive procedures, and the cranial module supports biopsies and deep brain stimulation.1
Pricing
Globus sells by quote. Buyers should ask about system price, instrument sets, and any implant commitments.1
Competitive landscape
| Company | Product | Pricing model | Deployment evidence | Where ExcelsiusGPS wins or loses |
|---|---|---|---|---|
| Globus Medical ExcelsiusGPS | Rigid arm plus full navigation, CT or fluoroscopy1 | Quote; spec sheet by request1 | 141.0 million dollars of enabling technology sales in 20252 | Spine specialist; tied to Globus instruments |
| TINAVI | TiRobot II for spine, trauma, and joint surgery10 | Quote; no prices published10 | More than 180,000 cases at more than 200 hospitals3 | TINAVI wins on one robot for spine, trauma, and joint cases. ExcelsiusGPS wins on rigid trajectory guidance with flexible imaging. |
| Stryker Mako SmartRobotics | Mako 4 with CT planning and AccuStop haptics6 | Quote; no prices published6 | More than two million procedures in more than 45 countries5 | Mako wins on the largest base of robotic joint procedures. ExcelsiusGPS wins on rigid trajectory guidance with flexible imaging. |
| THINK Surgical TMINI | Handheld, wireless knee robot with TPLAN planning8 | Quote; demo by request8 | 5,000 procedures by May 20268 | TMINI wins on a small knee robot open to many implants. ExcelsiusGPS wins on rigid trajectory guidance with flexible imaging. |
| eCential Robotics | Imaging, navigation, and robotics in one platform9 | Quote; demo by request9 | More than 3,500 surgeries9 | eCential wins on built-in 3D imaging with any brand of screw. ExcelsiusGPS wins on rigid trajectory guidance with flexible imaging. |
| Curexo | CUVIS-joint fully automatic knee robot, CUVIS-spine navigation, MorningWalk11 | Quote11 | More than 100 CUVIS-joint installs; Korea, India, US, Australia launches12 | Curexo wins on fully automatic bone cutting on an open implant platform. ExcelsiusGPS wins on spine navigation tied to a big implant catalog. |
Limits
No published price.1
No published installed base.2
Designed around Globus instruments and implants.1
What customers say
Where it helps
Works with any preoperative CT, intraoperative CT, or fluoroscopy system.1
Where it falls short
Enabling technology sales fell in 2025 before a strong fourth quarter.2
Company backing
Globus Medical reported 2025 net sales of 2.94 billion dollars, far above the range for our full reviews, so this page is scoped to ExcelsiusGPS.2
Sources
- Globus Medical, ExcelsiusGPS product page, accessed November 9, 2026
- Globus Medical, fourth quarter and full year 2025 results, SEC Form 8-K exhibit 99.1, accessed November 9, 2026
- TINAVI, About TINAVI, accessed November 9, 2026
- Eastmoney (China Securities Journal), TINAVI 2025 total operating revenue 279 million yuan, up 55.9%, April 29, 2026, accessed November 9, 2026
- Stryker, 2025 Comprehensive Report, accessed November 9, 2026
- Stryker, Mako SmartRobotics overview, accessed November 9, 2026
- Stryker, fourth quarter and full year 2025 results, SEC Form 8-K exhibit 99.1, accessed November 9, 2026
- THINK Surgical, homepage and news, accessed November 9, 2026
- eCential Robotics, homepage, accessed November 9, 2026
- TINAVI, TiRobot II product page, accessed November 9, 2026
- Curexo, CUVIS-joint, accessed November 13, 2026
- Curexo, History, accessed November 13, 2026
- Curexo, 2025 business report filed with the Korea Exchange (March 17, 2026), accessed November 13, 2026

